DAYMARK WEALTH PARTNERS, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1956824
CINCINNATI, OH
Position in REGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$728,599
+$474,654 QoQ
Shares Held
943
+186.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAYMARK WEALTH PARTNERS, LLC holds $5,277,793 across 8 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
|
55,834 | $3,067,519 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,193 | $592,598 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
56,734 | $322,249 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
8,000 | $312,080 | |
| 5 | MRNA |
Moderna, Inc.
|
4,103 | $287,333 | |
| 6 | RPRX |
Royalty Pharma plc
|
4,568 | $256,127 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,186 | $227,760 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,994 | $212,127 |
All Filings in REGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $728,599 | 943 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $253,945 | 329 | Shares | Sole | 2026-01-12 | |
| 2025-03-31 | $331,702 | 523 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $244,329 | 343 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $373,190 | 355 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $310,053 | 295 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $333,984 | 347 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $304,766 | 347 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $203,271 | 247 | Shares | Sole | 2023-10-10 | |
| 2023-03-31 | $203,774 | 248 | Shares | Sole | 2023-04-20 | |
| No filing history on record for this holder in this stock. | ||||||